VC-backed PageScience names new advertising sales VP

PageScience, a New York-based provider of contextual advertising technology, has hired Steve McEvoy as a vice president of advertising sales. Previously, McEvoy worked at Mochilla and Jumpstart. The company’s backers include Metamorphic Ventures and Cava Capital.


NEW YORK–(BUSINESS WIRE)–PageScience, the leading source for page-level targeting, has named Steve McEvoy as a VP-Advertising Sales, reporting to CEO Bill Jennings.
McEvoy brings more than 10 years of digital ad sales experience, most recently as Director-Digital Ad Sales at HealthGuru. Previously, he held key digital ad sales positions at Mochilla, a leading syndication and technology platform, and Jumpstart, an automotive ad network acquired by Hachette Publications. In these positions, Steve worked closely with leading brands including Bayer, Glaxo, Lilly, Ford, GM, Audi, BMW and Chrysler.
“Steve brings an ideal combination of health and auto ad sales experience to PageScience at a key point in our growth” said Jennings. “As we expand our programmatic targeting solutions to new sectors, we are rapidly hiring category experts. Steve has a deep understanding of pharma digital goals in addition to industries like auto and travel and will significantly expand our ability to reach the marketplace. Brands seek context, reach and premium environments and PageScience delivers this with great customer service and a reporting dashboard that provides strong page-level analytics.”
“I am very excited to join PageScience at this rapid phase of the company’s growth. PageScience pioneered “cookieless” page level targeting for pharma over four years ago under the Precision Health Media brand and is well positioned to offer its platform to other brand categories,” stated McEvoy.
PageScience’s technology, PageMatch™, scores pages based on contextual relevance, historical performance, viewability and other inputs, and has a deep integration with AppNexus to analyze of 20 billion impressions per day.
About PageScience
New York-based PageScience, formerly Precision Health Media, delivers vast reach and precise page-level targeting to brands. The company is backed by Metamorphic Ventures, Cava Capital, Hub Angels and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). PageMatch is a trademark of PageScience. For more information, visit



Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.